Related by context. Frequent words. (Click for all words.) 74 CHEAP ONLINE PHARMACY LOW 74 PRICE GREAT DISCOUNT FREE 73 fumarate 73 CHEAP ONLINE PHARMACY BEST 73 refractory chronic lymphocytic 73 Coadministration 73 FDA Accepts 72 PRICES GREAT DISCOUNTS 72 Panzem R 72 IS FOR INFORMATIONAL 72 injection USP 71 Pivotal Phase III 71 Drug Candidate 71 Completes Enrollment 71 CONTAIN FORWARD LOOKING STATEMENTS 71 CONTAINS FORWARD LOOKING STATEMENTS 71 * LW# * 71 J Am Acad 71 PURSUANT TO THE 71 Recombinant Human 71 Presents Positive 70 TO BUY OR 70 BELIEVES THAT THE 70 THE INFORMATION PROVIDED 70 sodium phosphate monobasic monohydrate 70 AND CONDITIONS OF 70 Generic Version 70 J Am Coll 70 SUCH FORWARD LOOKING STATEMENTS 70 die besten Deutsche 70 THAT COULD CAUSE ACTUAL 70 pseudobulbar affect PBA 70 BEST ONLINE PHARMACY LOWEST 70 sodium phosphate dibasic anhydrous 70 Copegus R 70 PIG VIRUS THEY SHOULD 70 PRICE FOR EXCELLENT 70 ACTUAL RESULTS TO DIFFER 69 RESULTS TO DIFFER 69 OFFER TO PURCHASE 69 WE URGE INVESTORS 69 IS NOT AN OFFER 69 TH STAFF WRITER 69 DECISION WITH RESPECT TO 69 HAS BEEN PREPARED BY 69 ferric citrate 69 PRESS RELEASE ARE FORWARD 69 IT CONTAINS IMPORTANT INFORMATION 69 SHALL NOT CONSTITUTE AN 69 BELIEFS PLANS EXPECTATIONS OR 69 Surgical Adhesive 69 * MINOR FLOODING 69 voriconazole 69 'S ABILITY AND 69 humanized anti 69 R sorafenib tablets 69 Application MAA 69 HISTORICAL INFORMATION PRESENTED HEREIN 69 WEB SITE OR 69 liposomal formulation 69 AND THE COMPANY 69 online Casinos und 69 READ THE PROXY 69 THE AMERICANS HAVE 69 INVESTORS ARE URGED TO 69 INTENTIONS CONTAINED IN 69 THE REPORTING 69 Aradigm Corporation 69 EXPRESSED OR IMPLIED 69 THAT ARE SUBJECT TO 69 IT WILL CONTAIN 68 Onalta 68 Extended Release Tablets 68 post herpetic neuralgia PHN 68 Oral Solution 68 THE COMPANY 'S PERIODIC 68 KNOWN AND UNKNOWN RISKS 68 MATTERS DISCUSSED IN 68 STOCKHOLDERS ARE URGED TO 68 WHICH ARE NOT PURELY 68 ARE MADE AS 68 Rebif ® 68 Extended Release 68 REGULATORY APPROVAL PROCESS COMPETITIVE 68 ENQUIRER STAFF WRITER 68 dipropionate 68 Phase III Clinical Trial 68 而 68 Pegasys ® 68 CERTAIN RISKS AND UNCERTAINTIES 68 THE TENDER OFFER STATEMENT 68 Positive Opinion 68 MKC# 68 #.#secs P 68 Ascorbic Acid 68 Eltrombopag 68 THE ACTUAL RESULTS 68 PURPOSES ONLY AND DOES 68 ANY RESPONSIBILITY FOR ANY 68 BELIEFS PLANS EXPECTATIONS AND 68 INTEREST AFFILIATE FIREWALL COMPLIANCE